Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

Clinical trial NCT00610493 · COMPLETED

Trial details

NCT number: NCT00610493
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-01-25
Primary completion: 2017-11-28
Enrollment: 193

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.